Lifeline Scientific (LSI) Share Price, News & Analysis

Company Overview

Lifeline Scientific, Inc. is engaged in the provision of products and services for cell, tissue and organ transplantation. The Company sells LifePort Kidney Transporter, related disposables and consumables, and develops future medical devices and related products. It operates in two business units: Organ Recovery Systems and Cell and Tissue Systems (CTS). Organ Recovery Systems, which develops medical devices, flush and preservation solutions and protocols to improve the process by which donor organs are preserved,from the time of donation to the time of transplantation. Cell and Tissue Systems operates an applied cryobiology and cell therapy research facility focused on improving the long-term storage of living biological materials. It performs scientific research for in vitro diagnostics and allograft cells and tissues, such as heart valves, saphaneous veins and pancreatic islets for transplantation.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 244 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LSI Stock Analysis - Frequently Asked Questions

How do I buy shares of Lifeline Scientific?

Shares of LSI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Finance
• Industry: Other Financial Vehicles
• Sub-Industry: N/A
• Current Symbol: LON:LSI
• CIK: N/A
• Web: lifeline-scientific.com
• Phone: +1-847-2940300
• Fax: N/A
• Employees: 2,018
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A